Hugues Chanteux

2.2k total citations · 1 hit paper
39 papers, 1.7k citations indexed

About

Hugues Chanteux is a scholar working on Pediatrics, Perinatology and Child Health, Oncology and Psychiatry and Mental health. According to data from OpenAlex, Hugues Chanteux has authored 39 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pediatrics, Perinatology and Child Health, 13 papers in Oncology and 12 papers in Psychiatry and Mental health. Recurrent topics in Hugues Chanteux's work include Pharmacological Effects and Toxicity Studies (15 papers), Drug Transport and Resistance Mechanisms (12 papers) and Epilepsy research and treatment (12 papers). Hugues Chanteux is often cited by papers focused on Pharmacological Effects and Toxicity Studies (15 papers), Drug Transport and Resistance Mechanisms (12 papers) and Epilepsy research and treatment (12 papers). Hugues Chanteux collaborates with scholars based in Belgium, United Kingdom and United States. Hugues Chanteux's co-authors include Brigitte Gerin, Paul M. Tulkens, Marie‐Paule Mingeot‐Leclercq, Franck A. Atienzar, Karen Tilmant, B. O. Depelchin, Helga H.J. Gerets, Stéphane Dhalluin, Françoise Van Bambeke and Jean‐Marie Nicolas and has published in prestigious journals such as Neurology, Gut and Journal of Medicinal Chemistry.

In The Last Decade

Hugues Chanteux

38 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins

2012 551 citations Helga H.J. Gerets, Karen Tilmant et al. Cell Biology and Toxicology profile →

Peers

Countries citing papers authored by Hugues Chanteux

Since Specialization

Citations

This map shows the geographic impact of Hugues Chanteux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugues Chanteux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugues Chanteux more than expected).

Fields of papers citing papers by Hugues Chanteux

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugues Chanteux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugues Chanteux. The network helps show where Hugues Chanteux may publish in the future.

Co-authorship network of co-authors of Hugues Chanteux

This figure shows the co-authorship network connecting the top 25 collaborators of Hugues Chanteux. A scholar is included among the top collaborators of Hugues Chanteux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugues Chanteux. Hugues Chanteux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluating the pharmacodynamic effects of padsevonil in healthy volunteers using simultaneous [11C]-UCB-J PET and MR Arterial Spin Labeling measurements 2023 ·Neuroscience Applied ·Michel Koole, Brigitte Lacroix, (unknown), Hugues Chanteux, R. P. Maguire, Koen Van Laere	1
2	Clinical Bridging Studies and Modeling Approach for Implementation of a Patient Centric Sampling Technique in Padsevonil Clinical Development 2023 ·The AAPS Journal ·(unknown), (unknown), Christian Otoul, (unknown), M. Macpherson, Mark Watling, Massimo Bani, David Sciberras, Hugues Chanteux	4
3	(–)-N-3-Benzylphenobarbital Is Superior to Omeprazole and (+)-N-3-Benzylnirvanol as a CYP2C19 Inhibitor in Suspended Human Hepatocytes 2020 ·Drug Metabolism and Disposition ·(unknown), Hugues Chanteux, (unknown), (unknown), Kenneth Saunders, (unknown), Claude Delatour, (unknown), Anna‐Lena Ungell, Johan Nicolaï	3
4	Impact of In Vitro Passive Permeability in a P-gp-transfected LLC-PK1 Model on the Prediction of the Rat and Human Unbound Brain-to-Plasma Concentration Ratio 2020 ·Pharmaceutical Research ·Johan Nicolaï, Hélène Chapy, (unknown), Kenneth Saunders, Anna‐Lena Ungell, Jean‐Marie Nicolas, Hugues Chanteux	12
5	A review of the drug−drug interactions of the antiepileptic drug brivaracetam 2020 ·Epilepsy Research ·Brian D. Moseley, Hugues Chanteux, Jean‐Marie Nicolas, (unknown), Barry E. Gidal, Armel Stockis	39
6	Role of P-glycoprotein in the brain disposition of seletalisib: Evaluation of the potential for drug-drug interactions 2019 ·European Journal of Pharmaceutical Sciences ·Jean‐Marie Nicolas, Hugues Chanteux, Johan Nicolaï, (unknown), (unknown), (unknown), (unknown), (unknown), François‐Xavier Mathy, (unknown), Eric Helmer	3
7	Off-line solid phase extraction and liquid chromatography-tandem mass spectrometry method for the quantitation of brivaracetam acid metabolites: Method validation and application to in vitro metabolism assays 2018 ·Journal of Chromatography B ·E. Bourgogne, (unknown), (unknown), Hugues Chanteux, Armel Stockis, Jean‐Marie Nicolas	6
8	Role of the OATP Transporter Family and a Benzbromarone-SensitiveEfflux Transporter in the Hepatocellular Disposition of Vincristine 2017 ·Pharmaceutical Research ·Johan Nicolaï, (unknown), Bing Qi, Bruno Stieger, Hugues Chanteux, Patrick Augustijns, Pieter Annaert	8
9	Effect of Rifampin on the Disposition of Brivaracetam in Human Subjects: Further Insights into Brivaracetam Hydrolysis 2016 ·Drug Metabolism and Disposition ·Armel Stockis, Shikiko Watanabe, André Scheen, D. Tytgat, Brigitte Gerin, Mónica Rosa, Hugues Chanteux, Jean‐Marie Nicolas	36
10	In Vitro Pharmacokinetic Profile of Brivaracetam (BRV) Reveals Low Risk of Drug-Drug Interaction (DDI) and Unrestricted Brain Permeability (P4.276) 2015 ·Neurology ·Hugues Chanteux, Sophie Kervyn, Brigitte Gerin, Maria De Rosa, (unknown), Armel Stockis, Jean‐Marie Nicolas	4
11	Brivaracetam and carbamazepine interaction in healthy subjects and in vitro 2015 ·Epilepsy Research ·Armel Stockis, Hugues Chanteux, Maria De Rosa, Paul Rolan	43
12	Cross-Species Differences in the Preclinical Pharmacokinetics of CT7758, an α4β1/α4β7 Integrin Antagonist 2015 ·Drug Metabolism and Disposition ·Hugues Chanteux, Ludovicus Staelens, (unknown), Brigitte Gerin, (unknown), Chandra Prakash, Jean‐Marie Nicolas	10
13	N-Alkylprotoporphyrin Formation and Hepatic Porphyria in Dogs After Administration of a New Antiepileptic Drug Candidate: Mechanism and Species Specificity 2014 ·Toxicological Sciences ·Jean‐Marie Nicolas, Hugues Chanteux, (unknown), (unknown), Brigitte Gerin, Ludovicus Staelens, (unknown), Sophie Kervyn	6
14	In Vitro Hydrolysis and Transesterification of CDP323, an α4β1/α4β7 Integrin Antagonist Ester Prodrug 2013 ·Drug Metabolism and Disposition ·Hugues Chanteux, Maria De Rosa, Claude Delatour, Chandra Prakash, Steven J. Smith, Jean‐Marie Nicolas	11
15	Effect of Gemfibrozil on the Metabolism of Brivaracetam In Vitro and in Human Subjects 2012 ·Drug Metabolism and Disposition ·(unknown), Hugues Chanteux, Maria De Rosa, Shikiko Watanabe, Armel Stockis	35
16	Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins breakdown → 2012 ·Cell Biology and Toxicology ·Helga H.J. Gerets, Karen Tilmant, Brigitte Gerin, Hugues Chanteux, B. O. Depelchin, Stéphane Dhalluin, Franck A. Atienzar	551
17	Assessment of cytochrome P450 (1A2, 2B6, 2C9 and 3A4) induction in cryopreserved human hepatocytes cultured in 48-well plates using the cocktail strategy 2012 ·Xenobiotica ·Brigitte Gerin, (unknown), Lysiane Richert, Steven J. Smith, Hugues Chanteux	16
18	LPS induces IL-10 production by human alveolar macrophages via MAPKinases- and Sp1-dependent mechanisms 2007 ·Respiratory Research ·Hugues Chanteux, (unknown), Charles Pilette, Yves Sibille	137
19	Influence of P-Glycoprotein Inhibitors on Accumulationof Macrolides in J774 MurineMacrophages 2003 ·Antimicrobial Agents and Chemotherapy ·Cristina Seral, (unknown), Hugues Chanteux, Marie‐Paule Mingeot‐Leclercq, Paul M. Tulkens, Françoise Van Bambeke	60
20	Saccharomyces boulardii upgrades cellular adaptation after proximal enterectomy in rats 1999 ·Gut ·(unknown), Nadine De Keyser, (unknown), D. Hermans, Étienne Sokal, (unknown), Luc Lambotte, Hugues Chanteux, Paul M. Tulkens	63

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact